Pasar al contenido principal

Nanotransportadores Proteicos Humanos Ingenierizados para la Entrega Segura y Específica de Terapias Moleculares

PTQ2024-013788

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de Recursos Humanos
Subprograma Subprograma Estatal de Formación, Atracción y Retención del Talento Investigador e Innovador
Convocatoria Torres Quevedo
Año convocatoria 2024
Plan Estatal 2024-2027 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario DNAMIC BIOTECH S.L.

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Emerging biomodels to understand the pathophysiology of sepsis and evaluate new therapeutic strategies targeting extracellular histones

  • Garcia-Gimenez, Jose Luis
  • Cervera, Marta Seco
  • Canovas-Cervera, Irene
  • Agundez, Ana Belen
  • Dolz-Andres, Enric
  • Mondaray-Munoz, Gonzalo
  • Calpe-Fortea, Rosa
  • Nacher-Sendra, Elena
  • Osca-Verdegal, Rebeca
  • Beltran-Garcia, Jesus
  • Sierra-Rivera, Antonio
  • Peiro-Chova, Lorena
  • Ibañez-Cabellos, J.S.
  • Aparicio-Collado, José Luís|||0000-0003-0874-9131
  • Gallego-Ferrer, Gloria|||0000-0002-2428-0903
[EN] Background: Extracellular histones (extH) have emerged as key damage-associated molecular patterns (DAMPs) driving multi-organ failure in sepsis. Despite their correlation with disease severity, organ-specific mechanisms of extH toxicity and targeted therapeutic strategies remain underexplored. Main body: This review dissects extH-mediated pathophysiology across vital organs including heart, lungs, kidneys, liver, and brain, through convergent pathways including TLR activation, NLRP3 inflammasome signaling, NETosis, oxidative stress, calcium influx, pyroptosis, and microvascular thrombosis. Conventional 2D cell cultures fail to recapitulate tissue architecture, multicellular interactions, and hemodynamic forces, while rodent models exhibit poor clinical translatability due to specific immune responses and physiology. Moreover, conventional 2D models and animal models do not usually cover the heterogenicity we can find in sepsis. In contrast, advanced human-relevant 3D biomodels offer transformative advantages: organoids faithfully recreate organ-specific cellular heterogeneity and developmental gradients; 3D-bioprinted biomodels provide precise spatial control of immune-endothelial-stromal interactions within biomimetic matrices; organ-on-chip platforms integrate physiological shear stress, dynamic flow, oxygen gradients, and real-time inter-organ communication, enabling study of extH-driven neutrophil adhesion, platelet aggregation, barrier dysfunction, and cytokine storms under clinically relevant conditions. Conclusion: Next-generation 3D biomodels overcome traditional translational barriers, facilitating the comprehension of the pathophysiological mechanisms occurring in tissues during sepsis. Moreover, these advanced biomodels enable high-throughput screening of extH-neutralizing agents (e.g., heparinoids, anti-histone antibodies) and hemoperfusion technologies, thereby advancing precision intensive care medicine. By bridging mechanistic insights to clinical strategies that mitigate inflammation, endothelial dysfunction, thrombosis and long-term sequelae, these platforms promise transformative advances in sepsis management and intensive care outcomes., We would like to thank all the funding bodies supporting our research projects, including the EIC Accelerator programme, supported by CDTI - NextGenerationEU (Ministerio de Ciencia, Innovacion y Universidades) , as well as the projects CPP2021/008643 and DTS24/00094 funded by the Spanish Ministry of Science and Innovation, projects PI22-00481 and PI25-00664 funded under the Accion Estrategica en Salud programme of the Instituto de Salud Carlos III (Spanish Ministry of Science and Innovation) and the CIAICO/2023/168, CIAPOT/2024/19 and CIPROM/2022/43 PROMETEO project from Generalitat Valenciana. I.Canovas-Cervera thanks the Ministry of Science, Innovation, and Universities for FPU grant (FPU23/02919) J. Aparici-Collado would like to thank Agencia Espanola de Investigacion for a grant Torres Quevedo (PTQ2024-013788) .